| eGenesis Inc.. (11/7/19). "Press Release: eGenesis Announces $100 Million Series B Financing". Cambridge, MA. |
2019-11-07 |
| Waters Corporation. (11/7/19). "Press Release: World’s First Cyclic IMS Mass Spectrometer Installed at Aston University". Milford, MA. |
2019-11-07 |
| Centogene B.V.. (11/7/19). "Press Release: Centogene Announces Pricing of Initial Public Offering". Cambridge, MA & Rostock. |
2019-11-07 |
| BC Platforms. (11/7/19). "Press Release: BC Platforms Opens New Entity in Singapore to Spearhead its Asia Pacific Strategy and Hosts Launch Event in Precision Medicine". Zürich & Boston, MA. |
2019-11-07 |
| Owlstone Medical Ltd.. (11/7/19). "Press Release: Owlstone Medical Enters Partnership with Thermo Fisher Scientific to Advance Early Disease Detection Using Non-invasive Breath Biopsy". Cambridge. |
2019-11-07 |
| Argenx SE. (11/7/19). "Press Release: Argenx Raises $484 Million in Gross Proceeds in a Global Offering". Breda & Ghent. |
2019-11-07 |
| Teva Pharmaceutical Industries Ltd.. (11/7/19). "Press Release: Teva Announces Appointment of New Chief Financial Officer". Jerusalem. |
2019-11-07 |
| Urania Therapeutics S.A.S.. (11/6/19). "Press Release: Urania Therapeutics Closes a €3.5M Initial Seed Round". Strasbourg. |
2019-11-06 |
| AstraZeneca plc. (11/6/19). "Press Release: AstraZeneca Announces Three Large-scale Initiatives in China to Advance Global Medicine Research and Development". |
2019-11-06 |
| Ervaxx Ltd.. (11/6/19). "Press Release: Ervaxx Launches to Pioneer the Use of Dark Antigens for the Development of Off-the-Shelf Cancer Vaccines and T-cell Receptor-based Immunotherapies". London. |
2019-11-06 |
| Evotec SE. (11/6/19). "Press Release: Evotec and Vifor Pharma Form Joint Venture for Early Development in Nephrology". Hamburg & St. Gallen. |
2019-11-06 |
| Argenx SE. (11/6/19). "Press Release: Argenx Announces Launch of Proposed Global Offering". Breda & Ghent. |
2019-11-06 |
| Acticor Biotech S.A.S.. (11/6/19). "Press Release: Acticor Biotech Raises €7m in Addition to Its Series B Financing, Now Completed at €22.3m". Paris. |
2019-11-06 |
| Rentschler Biopharma SE. (11/6/19). "Press Release: Rentschler Biopharma Kicks off Expansion at U.S. Facility in the Boston Biotech Hub". Laupheim & Milford, MA. |
2019-11-06 |
| Greenough. (11/6/19). "Press Release: Agencies Align Life Science/Healthcare Expertise to Offer Integrated Marketing Services on Both Sides of the Pond". Watertown, MA. |
2019-11-06 |
| Artios Pharma Ltd.. (11/6/19). "Press Release: Artios Pharma, MD Anderson and ShangPharma Announce In-licensing Agreement for DNA Damage Response Inhibitor". Cambridge, New York, NY, Houston, TX & South San Franicsco, CA. |
2019-11-06 |
| Poxel S.A.. (11/5/19). "Press Release: Poxel Obtains Additional Funding to Advance Pipeline Programs. Financing of up to EUR 30 Million through a Bond Loan with IPF Partners". Lyon. |
2019-11-05 |
| Acticor Biotech S.A.S.. (11/5/19). "Press Release: Acticor Biotech Partner of the BOOSTER Consortium Dedicated to Management and New Treatments of Stroke in Emergeny Situations". Paris. |
2019-11-05 |
| ADC Therapeutics S.A.. (11/5/19). "Press Release: ADC Therapeutics Appoints Jennifer Herron as Chief Commercial Officer". Lausanne. |
2019-11-05 |
| SciRhom GmbH. (11/5/19). "Press Release: SciRhom Initiates First-In-Class Antibody Development Program to Treat Major Autoimmune Diseases". Munich. |
2019-11-05 |
| Boehringer Ingelheim. (11/4/19). "Press Release: Boehringer Ingelheim and Lilly Modernise Alliance to Focus Full Expertise on Jardiance". Ingelheim & Indianapolis, IN. |
2019-11-04 |
| Xlife Sciences AG. (11/4/19). "Press Release: Xlife Siences AG. New Project in the Portfolio". Zurich. |
2019-11-04 |
| Zelluna Immunotherapy AS. (11/4/19). "Press Release: Zelluna Immunotherapy Appoints Dr Bent Jakobsen, a Pioneer of TCR Therapeutics, to the Board of Directors". Oslo. |
2019-11-04 |
| Pieris Pharmaceuticals, Inc.. (11/4/19). "Press Release: Pieris Pharmaceuticals Announces $32 Million Private Placement and Potential Funding Mechanism for PRS-060 Co-development Opt-in". Boston, MA. |
2019-11-04 |
| Santhera Pharmaceuticals AG. (11/4/19). "Press Release: Santhera Appoints New Chief Executive Officer". Pratteln. |
2019-11-04 |
| Sangamo Therapeutics, Inc.. (11/1/19). "Press Release: Sangamo Therapeutics Appoints Sung Lee as Executive Vice President and Chief Financial Officer". Brisbane, CA. |
2019-11-01 |
| Fibit, Inc.. (11/1/19). "Press Release: Fitbit to Be Acquired by Google". San Francisco, CA. |
2019-11-01 |
| Roivant Sciences GmbH. (10/31/19). "Press Release: Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance". Tokyo, Osaka, London & Basel. |
2019-10-31 |
| Bicycle Therapeutics plc. (10/31/19). "Press Release: Bicycle Therapeutics Announces Appointment of Veronica Jordan, Ph.D., to Board of Directors". Cambridge & Boston, MA. |
2019-10-31 |
| Mesa Laboratories, Inc.. (10/31/19). "Press Release: Mesa Labs Acquires Gyros Protein Technologies". Lakewood, CO. |
2019-10-31 |
| AstraZeneca plc. (10/30/19). "Press Release: AstraZeneca Divests Rights to Seroquel and Seroquel XR in Europe and Russia". |
2019-10-30 |
| Genmab A/S. (10/30/19). "Press Release: David Eatwell to Retire as Chief Financial Officer of Genmab". Copenhagen. |
2019-10-30 |
| genOway S.A.. (10/30/19). "Press Release: The Institut Pasteur and Cellectis Extend Exclusive License Rights by Granting genOway the Authority to Take Action against Infringement". Lyon & Paris. |
2019-10-30 |
| Themis Bioscience GmbH. (10/29/19). "Press Release: Themis Bioscience and CEPI Announce Initiation of Phase 1 Clinical Trial with Lassa Fever Vaccine". Vienna & Oslo. |
2019-10-29 |
| CEM Corporation. (10/29/19). "Press Release: CEM Corporation Acquires Key Assets of Intavis Bioanalytical Instruments". Matthews, NC. |
2019-10-29 |
| Cellectis S.A.. (10/29/19). "Press Release: First Patient Dosed with Off-the-Shelf UCARTCS1 Product Candidate for Relapsed/Refractory Multiple Myeloma". New York, NY. |
2019-10-29 |
| Bicycle Therapeutics plc. (10/29/19). "Press Release: Bicycle Therapeutics Announces Appointment of Nigel Crockett, Ph.D., as Chief Business Officer". Cambridge & Boston, MA. |
2019-10-29 |
| Disc Medicine. (10/29/19). "Press Release: Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production". Cambridge, MA. |
2019-10-29 |
| Disc Medicine. (10/29/19). "Press Release: Disc Medicine Expands Pipeline Focused on Hepcidin Pathway.
Enters into Exclusive Agreement with AbbVie for Series of Hemojuvelin Antagonist Monoclonal Antibodies". Cambridge, MA. |
2019-10-29 |
| Boehringer Ingelheim. (10/29/19). "Press Release: Boehringer Ingelheim Advances First Pan-KRAS Inhibitor BI 1701963 into Clinical Testing". Ingelheim. |
2019-10-29 |
| Cato Research, LLC. (10/28/19). "Press Release: Cato Research Announces Merger with SMS-Oncology". Durham, NC. |
2019-10-28 |
| Curetis N.V.. (10/28/19). "Press Release: Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test". Vienna & Holzgerlingen. |
2019-10-28 |
| Parc Cientific de Barcelona (BCP, Barcelona Science Park Foundation). (10/28/19). "Press Release: Molomics Opens an Investment Round to Accelerate an Innovative Project against Parkinson’s". Planegg & Mechelen. |
2019-10-28 |
| CRISPR Therapeutics AG. (10/28/19). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2019 Financial Results". Zug & Cambridge, MA. |
2019-10-28 |
| OpGen, Inc.. (10/28/19). "Press Release: OpGen Announces Closing of $9.4 Million Underwritten Public Offering". Gaithersburg, MD. |
2019-10-28 |
| Centogene B.V.. (10/28/19). "Press Release: Centogene Announces Proposed Initial Public Offering of Common Shares". Cambridge, MA & Rostock. |
2019-10-28 |
| BiomX Ltd.. (10/28/19). "Press Release: Chardan Healthcare Acquisition Corp. Completes Merger with BiomX Ltd.". New York, NY & Ness Ziona. |
2019-10-28 |
| SP Industries, Inc.. (10/28/19). "Press Release: SP Acquires Spain Based i-Dositecno". Warminster, PA. |
2019-10-28 |
| Uniqure N.V.. (10/28/19). "Press Release: Uniqure Announces Third Quarter 2019 Results and Highlights Recent Company Progress". Lexington, MA & Amsterdam. |
2019-10-28 |
| Editas Medicine, Inc.. (10/28/19). "Press Release: Editas Medicine Appoints Judith R. Abrams, M.D., as Chief Medical Officer". Cambridge, MA. |
2019-10-28 |
| MorphoSys AG. (10/28/19). "Press Release: MOR106 Clinical Development in Atopic Dermatitis Stopped for Futility". Planegg & Mechelen. |
2019-10-28 |
| Galapagos N.V.. (10/25/19). "Press Release: Galapagos Receives Transparency Notification from Wellington Management Group LLP". Mechelen. |
2019-10-25 |
| AstraZeneca plc. (10/24/19). "Press Release: Year-to-Date and Q3 2019 Results". |
2019-10-24 |
| Pepticom. (10/24/19). "Press Release: Pepticom Raises $5 Million in Series A Funding. Jerusalem-based Startup Uses AI to Accelerate Drug Discovery". Jerusalem. |
2019-10-24 |
| Galapagos N.V.. (10/24/19). "Press Release: Solid Third Quarter 2019 Performance with Strong Balance Sheet for Continued R&D Growth". Mechelen. |
2019-10-24 |
| BiomX Ltd.. (10/23/19). "Press Release: Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona. |
2019-10-23 |
| Evotec SE. (10/23/19). "Press Release: Evotec, Integra Holdings and Yissum Establish LAB555 to Fast Track Early-stage Drug Development". Hamburg. |
2019-10-23 |
| OpGen, Inc.. (10/23/19). "Press Release: OpGen Announces Pricing of $9.4 Million Underwritten Offering". Gaithersburg, MD. |
2019-10-23 |
| Cision Ltd.. (10/22/19). "Press Release: Cision Ltd. Announces Agreement to Be Acquired by an Affiliate of Platinum Equity for $10.00 Per Share in All Cash Deal Valued at Approximately $2.74 Billion". Chicago. |
2019-10-22 |
| H. Lundbeck A/S. (10/22/19). "Press Release: Lundbeck Completes the Acquisition of Alder BioPharmaceuticals – a Company Committed to Transforming Migraine Treatment and Prevention". Valby. |
2019-10-22 |
| Arnold & Porter LLP. (10/22/19). "Press Release: Life Sciences Lawyer and Former EMA Legal Adviser Alexander Roussanov Joins Arnold & Porter in Brussels". Brussels. |
2019-10-22 |
| Bicycle Therapeutics plc. (10/22/19). "Press Release: Bicycle Therapeutics Expands Neuroscience Collaborations to include Oxford University’s Oxford Drug Discovery Institute". Cambridge & Boston, MA. |
2019-10-22 |
| Bluebird Bio, Inc.. (10/22/19). "Press Release: European Medicines Agency Approves Refined Commercial Manufacturing Specifications for Zynteglo". Cambridge, MA. |
2019-10-22 |
| PhagoMed Biopharma GmbH. (10/22/19). "Press Release: Phage Lysin Stabilzes Vaginal Microbiome. PhageMed Accelerates R6D Program against Bacterial Vaginosis". Vienna. |
2019-10-22 |
| MCG Motion Capture GmbH. (10/22/19). "Press Release: Motion Capture Group Retains Biotech Alliances International to Raise Series A $15 Million Financing Round". Heidelberg & San Francisco, CA. |
2019-10-22 |
| Zealand Pharma A/S. (10/22/19). "Press Release: Zealand Pharma Expands Its Peptide Platform with Acquisition of Encycle Therapeutics". Copenhagen. |
2019-10-22 |
| Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam. |
2019-10-22 |
| Sartorius AG. (10/21/19). "Press Release: Sartorius Signs Agreement to Acquire Select Danaher Life Science Platform Businesses". Göttingen. |
2019-10-21 |
| Bavarian Nordic A/S. (10/21/19). "Press Release: Bavarian Nordic Announces a Transformative Acquisition of Two Established Commercial Vaccines from GlaxoSmithKline". Copenhagen. |
2019-10-21 |
| Danaher Corporation. (10/21/19). "Press Release: Danaher Reaches Agreement to Sell Certain Businesses to Sartorius AG as Part of the GE Biopharma Acquisition Regulatory Process". Washington, DC. |
2019-10-21 |
| CRISPR Therapeutics AG. (10/21/19). "Press Release: CRISPR Therapeutics and Bayer Announce an Update on Casebia Therapeutics". Leverkusen, Zug & Cambridge, MA. |
2019-10-21 |
| Arcutis Biotherapeutics, Inc.. (10/21/19). "Press Release: Arcutis Announces the Completion of $94.5 Million Series C Financing". Westlake Village, CA. |
2019-10-21 |
| Biocat. (10/21/19). "Press Release: Boehringer Ingelheim Joins the d·HEALTH Barcelona Program to Foster Innovation in Health". Barcelona. |
2019-10-21 |
| ReViral Ltd.. (10/21/19). "Press Release: ReViral Announces Appointment of Alan Musso as Chief Financial Officer". London. |
2019-10-21 |
| Cancer Research UK. (10/21/19). "Press Release: International Alliance Sets Bold Research Ambition to Detect the (almost) Undetectable". |
2019-10-21 |
| Innate Pharma S.A.. (10/21/19). "Press Release: Innate Pharma Announces Closing of Global Offering". Marseille. |
2019-10-21 |
| Innate Pharma S.A.. (10/18/19). "Press Release: Innate Pharma Announces the Exercies in Full of the Option to the Underwriters of Its Global Offering and Nasdaq Global Select Market Listing to Purchase 1,87500 Additional ADSs". Marseille. |
2019-10-18 |
| Merck KGaA. (10/18/19). "Press Release: Merck Launches Seed Fund for Startups in China". Darmstadt. |
2019-10-18 |
| Avacta Group plc. (10/18/19). "Press Release: Proposed Placing and Subscription to Raise up to £9 Million and Notice of General Meeting". |
2019-10-18 |
| BC Platforms. (10/17/19). "Press Release: BC Platforms Partners with Blueprint Genetics to Provide Center of Excellence for Data Driven Testing Services in Rare Diseases". Zürich & Boston, MA. |
2019-10-17 |
| Kiadis Pharma N.V.. (10/17/19). "Press Release: Kiadis Pharma Provides Regulatory Update on ATIR101". Amsterdam. |
2019-10-17 |
| Sofinnova Partners. (10/17/19). "Press Release: Sofinnova Partners Raises €333 Million Capital IX Early-stage Healthcare Fund". Paris. |
2019-10-17 |
| Plexium, Inc.. (10/17/19). "Press Release: Plexium Launches with $28 Million in Series A Financing". San Diego, CA. |
2019-10-17 |
| Healx Ltd.. (10/16/19). "Press Release: Healx Secures $56m in Series B Financing, Launches Global Accelerator Programme for Rare Diseases". Cambridge. |
2019-10-16 |
| GammaDelta Therapeutics Ltd.. (10/16/19). "Press Release: Adaptate Biotherapeutics Formed to Develop Antibody-based Therapies that Modulate Gamma Delta T-cells". London. |
2019-10-16 |
| Amarna Therapeutics B.V.. (10/16/19). "Press Release: Amarna Therapeutics Raises €10 Million to Progress Lead Development Candidate into Clinical Trials and Appoints a New Supervisory Board". Leiden. |
2019-10-16 |
| Numab Therapeutics AG. (10/15/19). "Press Release: Numab Appoints Daniel Vasella to Board of Directors". Wädenswil (Zurich). |
2019-10-15 |
| CRISPR Therapeutics AG. (10/15/19). "Press Release: CRISPR Therapeutics and KSQ Therapeutics Announce License Agreement to Advance Companies’ Respective Cell Therapy Programs in Oncology". Zug & Cambridge, MA. |
2019-10-15 |
| Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. |
2019-10-15 |
| Gilead Sciences, Inc.. (10/15/19). "Press Release: Gilead Sciences Appoints Andrew Dickinson as Chief Financial Officer". Foster City, CA. |
2019-10-15 |
| Bit Bio Ltd.. (10/15/19). "Press Release: Elpis Becomes Bit Bio. We Are Excited to Announce Our Transition to the Cell Coding Company!". |
2019-10-15 |
| BiomX Ltd.. (10/15/19). "Press Release: BiomX Appoints Merav Bassan as Chief Development Officer". Ness Ziona. |
2019-10-15 |
| Cell Mogrify Ltd.. (10/14/19). "Press Release: Mogrify Raises Additional $16 Million to Advance Its Mission to Transform the Development of Life-saving Cell Therapies". Cambridge. |
2019-10-14 |
| MorphoSys AG. (10/14/19). "Press Release: MorphoSys and I-Mab Biopharma Announce IND Clearance to Initiate Clinical Trials of MOR202/TJ202 for the Treatment of Multiple Myeloma in Mainland China". Planegg & Shanghai. |
2019-10-14 |
| BiomX Ltd.. (10/14/19). "Press Release: Chardan Healthcare Acquisition Corp. Announces Amendment to Merger Agreement with BiomX Ltd.". New York, NY & Ness Ziona. |
2019-10-14 |
| Evotec SE. (10/10/19). "Press Release: Just-Evotec Biologics and Biocon Biologics Sign Licensing Deal for a Biosimilar Asset". Hamburg, Seattle, WA & Bengaluru. |
2019-10-10 |
| BioNTech SE. (10/10/19). "Press Release: BioNTech Announces Pricing of Initial Public Offering". Mainz. |
2019-10-10 |
| Stilla Technologies S.A.S.. (10/10/19). "Press Release: Stilla Technologies Opens U.S. Subsidiary for Direct Commercial Operations Under the Leadership of Life Science Veteran". Beverly, MA. |
2019-10-10 |
| UCB S.A.. (10/10/19). "Press Release: UCB Agrees to Acquire Ra Pharmaceuticals". Brussels & Cambridge, MA. |
2019-10-10 |
| Galapagos N.V.. (10/10/19). "Press Release: Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis". Foster City, CA & Mechelen. |
2019-10-10 |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo-2019.png){kind=logo}
1 2 3 4 ... 170 171 172 
Date![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 650x65px](/banner/iito-20181119-650-065-lsus-life-sciences-usa-com.jpg)
![Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px](/banner/iito-20190621-650-089-life-sciences-asia.jpg)
![Picture [iito] LSUS iitoLifeScience Transatlantic Life Sciences 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
